A Phase I Clinical Study Evaluating the Pharmacokinetics and Safety of Hetrombopag Olamine Tablets in Subjects With Mild Hepatic Impairment (Child-Pugh Class A), Moderate Hepatic Impairment (Child-Pugh Class B), and Normal Hepatic Function
Latest Information Update: 26 Oct 2021
At a glance
- Drugs Hetrombopag (Primary)
- Indications Liver disorders
- Focus Pharmacokinetics
- Sponsors Jiangsu Hengrui Medicine Co.
- 26 Oct 2021 New trial record